Role of the DEK oncogene in the development of squamous cell carcinoma
Authors:
Open Access
- 12 July 2020
- journal article
- review article
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 25 (9) , 1563-1569
Abstract
DEK is a highly conserved nuclear factor that plays an important role in the regulation of multiple cellular processes.DEKwas discovered to be an oncogene as a fusion withNUP214gene, which results in producing DEK-NUP214 proteins, in a subset of patients with acute myeloid leukemia. Subsequently, DEK overexpression was reported in many cancers, thus DEK itself is considered to be an oncoprotein. DEK has been reported to play important roles in the progression of early and late stage squamous cell carcinoma (SCC) and is useful for early diagnosis of the disease. These findings have made DEK an attractive therapeutic target, especially for human papillomavirus (HPV)-associated SCC. However, the mechanism of DEK in SCC remains unclear. In this review, we discuss humanDEKoncogene-related SCC.Keywords
This publication has 54 references indexed in Scilit:
- DEK over expression as an independent biomarker for poor prognosis in colorectal cancerBMC Cancer, 2013
- Oncoprotein DEK as a tissue and urinary biomarker for bladder cancerBMC Cancer, 2011
- The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrityGenes & Development, 2011
- The human DEK oncogene stimulates β-catenin signaling, invasion and mammosphere formation in breast cancerOncogene, 2011
- Control of Tumorigenesis and Chemoresistance by the DEK OncogeneClinical Cancer Research, 2010
- Melanoma Proliferation and Chemoresistance Controlled by the DEK OncogeneCancer Research, 2009
- Overexpression of the Cellular DEK Protein Promotes Epithelial Transformation In vitro and In vivoCancer Research, 2009
- Dysplasia of the Upper Aerodigestive Tract Squamous EpitheliumHead and Neck Pathology, 2009
- Apoptosis Inhibition by the Human DEK Oncoprotein Involves Interference with p53 FunctionsMolecular and Cellular Biology, 2006
- DEK Expression is Controlled by E2F and Deregulated in Diverse Tumor TypeCell Cycle, 2006